Carbapenem-Resistant Klebsiella pneumoniae Infection and Its Risk Factors in Older Adult Patients

References

• Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(supp–1):S28–S36. doi:10.1093/infdis/jiw282
   PubMedGoogle Scholar
• Zhu WM, Yuan Z, Zhou HY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):1–13.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial resistance global report on surveillance. Available from: https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=7CD2D037F35036393D8BC456B03B1991?sequence=1. Accessed April 6, 2019.
   Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–318. doi:10.1179/2047773215Y.0000000030
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe - annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. Available from: https://ecdc.europa.eu/sites/portal/files/. Accessed November 30, 2018.
   Google Scholar
• Gupta N, Limbago BM, Patel JB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67. doi:10.1093/cid/cir202
   PubMed Web of Science ®Google Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161. doi:10.1128/AAC.45.4.1151-1161.2001
   PubMed Web of Science ®Google Scholar
• French CE, Coope C, Conway L, et al. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review. J Hosp Infect. 2017;95(1):3–45. doi:10.1016/j.jhin.2016.10.006
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratuary Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement Document M100-S20. Wayne PA: Clinical and Laboratory Standards Institute; 2010.
   Google Scholar
• Zhang Y, Guo LY, Song WQ, et al. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018;18(1):1–10. doi:10.1186/s12879-018-3160-3
   PubMed Web of Science ®Google Scholar
• Kang JS, Yi J, Ko MK, et al. Prevalence and risk factors of carbapenem-resistant enterobacteriaceae acquisition in an emergency intensive care unit in a tertiary hospital in Korea: a case-control study. J Korean Med Sci. 2019;34(18). doi:10.3346/jkms.2019.34.e140
   Web of Science ®Google Scholar
• Micozzi A, Gentile G, Minotti C, et al. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect Dis. 2017;17(1):1–12. doi:10.1186/s12879-017-2297-9
   PubMed Web of Science ®Google Scholar
• Wu D, Cai J, Liu J. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J. 2011;104(2):106–110. doi:10.1097/SMJ.0b013e318206063d
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhong J, Ding H, et al. Analysis of risk factors for carbapenem-resistant Klebsiella pneumoniae infection and its effect on the outcome of early infection after kidney transplantation. Front Cell Infect Microbiol. 2021;11:989. doi:10.3389/fcimb.2021.726282
   Web of Science ®Google Scholar
• Mędrzycka-Dąbrowska W, Lange S, Zorena K, et al. Carbapenem-resistant Klebsiella pneumoniae infections in ICU COVID-19 patients—a scoping review. J Clin Med. 2021;10(10):2067. doi:10.3390/jcm10102067
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 27th Informational Supplement. M100-S27. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149–163. doi:10.2217/fon.09.136
   PubMed Web of Science ®Google Scholar
• Mody L, Riddell J, Kaye K, et al. Common infections In: Williams BA, Chang A, Ahalt C, et al. editors. Current Diagnosis&Treatment: Geriatrics. 2nd ed. McGraw-Hill Education; 2014.
   Google Scholar
• Candevir Ulu A, Kurtaran B, Inal AS, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a seriousthreat in ICUs. Med Sci Monit. 2015;21:219–224. doi:10.12659/MSM.892516
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI, Kofteridis D, et al. Klebsiella pneumoniae Risk factors of carbapenem-resistant infections: a matched case control study. J Antimicrob Chemother. 2007;60(5):1124–1130. doi:10.1093/jac/dkm356
   PubMed Web of Science ®Google Scholar
• Gómez Rueda V, Zuleta Tobón JJ. Klebsiella pneumoniae Risk factors for infection with carbapenem-resistant: a case–case–control study. Colomb Med. 2014;45:54–60. doi:10.25100/cm.v45i2.1417
   PubMed Web of Science ®Google Scholar
• Mills JP, Talati NJ, Alby K, et al. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol. 2016;37(1):55–60. doi:10.1017/ice.2015.254
   PubMed Web of Science ®Google Scholar
• Orsi G, Bencardino A, Vena A, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case–control study. Infection. 2013;41(1):61–67. doi:10.1007/s15010-012-0354-2
   PubMed Web of Science ®Google Scholar
• Huang PH, Cheng YH, Chen WY, et al. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57(6):106342. doi:10.1016/j.ijantimicag.2021.106342
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Song N, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. J Glob Antimicrob Resist. 2020;21:306–313. doi:10.1016/j.jgar.2019.09.006
   PubMed Web of Science ®Google Scholar
• Peron EP, Hirsch AA, Jury LA, et al. Another setting for stewardship: high rate of unnecessary antimicrobial use in a veterans affairs long-term care facility. J Am Geriatr Soc. 2013;61(2):289. doi:10.1111/jgs.12099
   PubMed Web of Science ®Google Scholar
• Crnich CJ, Jump R, Trautner B, et al. Optimizing antibiotic stewardship in nursing homes: a narrative review and recommendations for improvement. Drugs Aging. 2015;32(9):699. doi:10.1007/s40266-015-0292-7
   PubMed Web of Science ®Google Scholar
• Borer A, Saidel-Odes L, Eskira S, et al. Klebsiella pneumoniae risk factors for developing clinical infection with carbapenem-resistant in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control. 2012;40(5):421–425. doi:10.1016/j.ajic.2011.05.022
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo LY, Song WQ, et al. Pneumoniae risk factors for carbapenem-resistant bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018;18(1):248.
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028–1033. doi:10.1128/AAC.01020-07
   PubMed Web of Science ®Google Scholar
• Singh SK, Sridhar GR. Infections and diabetes. Int J Diabetes Dev Ctries. 2015;35(2):59–62. doi:10.1007/s13410-015-0417-x
   Web of Science ®Google Scholar
• Castle SC, Uyemura K, Fulop T, et al. Host resistance and immune responses in advanced age. Clin Geriatr Med. 2007;23(3):463. doi:10.1016/j.cger.2007.03.005
   PubMed Web of Science ®Google Scholar
• Kofteridis DP, Valachis A, Dimopoulou D, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case–case-control study. J Infect Chemother. 2014;20(5):293–297. doi:10.1016/j.jiac.2013.11.007
   PubMed Web of Science ®Google Scholar
• Tian L, Tan R, Chen Y, et al. Klebsiella pneumoniae Epidemiology of bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016;5(1):48. doi:10.1186/s13756-016-0145-0
   PubMedGoogle Scholar
• Correa L, Martino MD, Siqueira I, et al. A hospital-based matched case–control study to identify clinical outcome andrisk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2013;13(1):80. doi:10.1186/1471-2334-13-80
   PubMedGoogle Scholar
• da Silva KE, Maciel WG, Sacchi FPC, et al. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol. 2016;65(65):547–553. doi:10.1099/jmm.0.000254
   PubMedGoogle Scholar
• Girmenia C, Rossolini GM, Piciocchi A, et al. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone Marrow Translant. 2015;50(2):282–288. doi:10.1038/bmt.2014.231
   PubMed Web of Science ®Google Scholar